EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Musculoskeletal complications of Cushing syndrome

Dorota Leszczyńska iD, Alicja Szatko iD, Lucyna Papierska iD, Wojciech Zgliczyński, Piotr Glinicki iD

Rheumatology · 31.08.2023 · 61 (4) · 271-282

DOI: 10.5114/reum/169889 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Rheumatology, online erschienen am 31.08.2023. Verfasst von Dorota Leszczyńska und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Centre of Postgraduate Medical Education, Bielanski Hospital, Warsaw, Poland. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prolonged exposure to an excess of glucocorticosteroids (GCs), both endogenous and exogenous, leads to a wide range of comorbidities, including cardiovascular, metabolic, psychiatric, and musculoskeletal disorders. The latter comprise osteopenia and osteoporosis leading to skeletal fractures and myopathy. Although endogenous hypercortisolemia is a rare disorder, GCs are among the most frequently prescribed drugs, often administered chronically and despite multiple side effects, impossible to taper off due to therapeutic reasons. The pathophysiology of the effect of GC excess on bone often leads to fractures despite normal or low-normal bone mineral density and it includes direct (mainly disturbance in bone formation processes, through inactivation of the Wnt/β-catenin signalling pathway) and indirect mechanisms (through suppressing the gonadal and somatotrophic axis, and also through antagonizing vitamin D actions). Glucocorticosteroid-induced fast-twitch, glycolytic muscles atrophy occurs due to increased protein catabolism and impaired synthesis. Protein degradation is a result of activation of the ubiquitin proteasome and the lysosomes stimulated through overexpression of several atrogenes (such as FOXO-1 and atrogin-1). This review will discuss pathophysiology, clinical presentation, prevention, and management of GC- induced osteoporosis (including calcium and vitamin D supplementation, and bisphosphonates) and myopathy associated with GC excess.

Schlagwörter

Stichwörter der Autor:innen

Cushing syndromeglucocorticosteroidsmuscular diseasesosteoporosis

Autor:innen und Institutionen

  • Department of Endocrinology, Centre of Postgraduate Medical Education, Bielanski Hospital, Warsaw, Poland.

ORCID-Profile: Dorota Leszczyńska, Alicja Szatko, Lucyna Papierska, Piotr Glinicki

Zitieren

APA

Leszczyńska, D., Szatko, A., Papierska, L., Zgliczyński, W., & Glinicki, P. (2023). Musculoskeletal complications of Cushing syndrome. Rheumatology, 61(4), 271-282. https://doi.org/10.5114/reum/169889

Vancouver

Leszczyńska D, Szatko A, Papierska L, Zgliczyński W, Glinicki P. Musculoskeletal complications of Cushing syndrome. Rheumatology. 2023;61(4):271-282. doi:10.5114/reum/169889

BibTeX
@article{Leszczyska2023,
  author = {Leszczyńska, Dorota and Szatko, Alicja and Papierska, Lucyna and Zgliczyński, Wojciech and Glinicki, Piotr},
  title = {Musculoskeletal complications of Cushing syndrome},
  journal = {Rheumatology},
  year = {2023},
  volume = {61},
  number = {4},
  pages = {271--282},
  doi = {10.5114/reum/169889}
}
Kostenlos starten →